Genomic Health: Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Great

Media coverage

• Title	Genomic Health: Secondary Analysis of Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Affirms Unique Ability of Oncotype DX Breast Recurrence Score to Predict Chemotherapy Benefit, Guiding Adjuvant Therapy with Even Great
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	3/06/19
  Persons	Joseph Sparano